Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Several clinical trials evaluated the effectiveness of GLP-1RAs in inducing weight loss in individuals with obesity, with or without concomitant T2DM
The clinical trials that produced the impressive 15 to 17% body weight reduction numbers were measured over 68 weeks, not 7 days
Limitations of Current Research Many studies are preclinical Human mechanistic trials remain limited Microbiome responses vary individually Diet, sleep, stress, and medications influence outcomes GLP-1 regulation is multi-factorial The microbiome is one variable within a complex endocrine network
Evidence also suggests omega-3 fatty acids can lower your blood triglyceride levels and slightly improve HDL (good cholesterol) levels
